cyklokapron
pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria · gastrointestinal haemorrhage. general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: · in obstetrical complications such as abruptio placentae and post-partum haemorrhage · in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase.
cyklokapron 100 mg/ml inj. sol. i.v. amp.
pfizer sa-nv - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 100 mg/ml - tranexamic acid
cyklokapron 100 mg/ml solution for injection/infusion
pfizer healthcare ireland - tranexamic acid - solution for injection/infusion - 100 milligram(s)/millilitre - amino acids; tranexamic acid
cyklokapron injection 100 mgml
pfizer private limited - tranexamic acid - injection - 100 mg/ml - tranexamic acid 100 mg/ml
cyklokapron 100 mg/ml inj. sol. i.v. amp.
pfizer sa-nv - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 500 mg - tranexamic acid
cyklokapron 100 mg/ml solution
pfizer canada ulc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics
cyklokapron inj 100mg-ml injection solution for injection
pfizer manufacturing belgium n.v., belgium - tranexamic acid - solution for injection - 100 mg/ml
cyklokapron 500mg/5ml solution for injection ampoules
pfizer ltd - tranexamic acid - solution for injection - 100mg/1ml
cyklokapron 100 mg/ml solution for injection/infusion
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tranexamic acid - solution for injection/infusion - tranexamic acid 500 mg/5ml - antihemorrhagics
tranexamic acid lumacina tranexamic acid 1000 mg/10 ml solution for injection ampoule
bridgewest perth pharma pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - intravenous administration,adults,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.